Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Oct;110(2):597–602. doi: 10.1111/j.1476-5381.1993.tb13852.x

Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cells.

C M Hoorn 1, R A Roth 1
PMCID: PMC2175927  PMID: 8242234

Abstract

1. Changes in the structural and functional integrity of endothelium have been recognized as relatively early features of delayed and progressive pulmonary vascular injury caused by the pyrrolizidine alkaloid, monocrotaline (MCT). Although a number of investigators have evaluated angiotensin-converting enzyme (ACE) activity in the lungs of rats treated with MCT, the exact nature of changes in activity of this enzyme and the role they may play in MCT pneumotoxicity remain controversial. 2. We examined the direct effects of monocrotaline pyrrole (MCTP), a toxic metabolite of MCT, on cultured endothelial cell ACE activity. Post-confluent monolayers of porcine or bovine pulmonary artery endothelial cells (PECs or BECs, respectively) were treated with a single administration of MCTP at time 0; then they were examined for their ability to degrade the synthetic peptide, [3H]-benzoyl-Phe-Ala-Pro. 3. In PECs, which are relatively insensitive to the direct cytolytic effects of MCTP, monolayer ACE activity was unchanged initially but gradually decreased within 4 days after treatment with a high concentration of MCTP (150 microM). This decrease was transient, and PEC monolayer ACE activity returned to the control value by 10 days post treatment. 4. BEC monolayer ACE activity was also unchanged initially but rapidly declined within 4 days after MCTP treatment and remained depressed throughout the post treatment period. BECs were quite sensitive to the cytolytic effects of MCTP and the decline in ACE activity occurred coincident with the decrease in monolayer cellularity and appearance of marked cytotoxicity. 5. We conclude that high concentrations of MCTP decrease endothelial ACE activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
597

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell L., Madri J. A. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol. 1990 Jul;137(1):7–12. [PMC free article] [PubMed] [Google Scholar]
  2. Booyse F. M., Sedlak B. J., Rafelson M. E., Jr Culture of arterial endothelial cells: characterization and growth of bovine aortic cells. Thromb Diath Haemorrh. 1975 Dec 15;34(3):825–839. [PubMed] [Google Scholar]
  3. Bruner L. H., Carpenter L. J., Hamlow P., Roth R. A. Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity. Toxicol Appl Pharmacol. 1986 Sep 30;85(3):416–427. doi: 10.1016/0041-008x(86)90349-2. [DOI] [PubMed] [Google Scholar]
  4. Bruner L. H., Hilliker K. S., Roth R. A. Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat. Am J Physiol. 1983 Aug;245(2):H300–H306. doi: 10.1152/ajpheart.1983.245.2.H300. [DOI] [PubMed] [Google Scholar]
  5. Catravas J. D., Burch S. E., Spurlock B. O., Mills L. R. Early effects of ionizing radiation on pulmonary endothelial angiotensin-converting enzyme and 5'-nucleotidase, in vivo. Toxicol Appl Pharmacol. 1988 Jul;94(3):342–355. doi: 10.1016/0041-008x(88)90276-1. [DOI] [PubMed] [Google Scholar]
  6. Chesney C. F., Allen J. R., Hsu I. C. Right ventricular hypertrophy in monocrotaline pyrrole treated rats. Exp Mol Pathol. 1974 Apr;20(2):257–268. doi: 10.1016/0014-4800(74)90058-6. [DOI] [PubMed] [Google Scholar]
  7. Del Vecchio P. J., Smith J. R. Expression of angiotensin-converting enzyme activity in cultured pulmonary artery endothelial cells. J Cell Physiol. 1981 Sep;108(3):337–345. doi: 10.1002/jcp.1041080307. [DOI] [PubMed] [Google Scholar]
  8. Dobuler K. J., Catravas J. D., Gillis C. N. Early detection of oxygen-induced lung injury in conscious rabbits. Reduced in vivo activity of angiotensin converting enzyme and removal of 5-hydroxytryptamine. Am Rev Respir Dis. 1982 Sep;126(3):534–539. doi: 10.1164/arrd.1982.126.3.534. [DOI] [PubMed] [Google Scholar]
  9. Erdös E. G. Angiotensin I converting enzyme. Circ Res. 1975 Feb;36(2):247–255. doi: 10.1161/01.res.36.2.247. [DOI] [PubMed] [Google Scholar]
  10. Fajardo L. F. The complexity of endothelial cells. A review. Am J Clin Pathol. 1989 Aug;92(2):241–250. doi: 10.1093/ajcp/92.2.241. [DOI] [PubMed] [Google Scholar]
  11. Gillis C. N., Catravas J. D. Altered removal of vasoactive substances in the injured lung: detection of lung microvascular injury. Ann N Y Acad Sci. 1982;384:458–474. doi: 10.1111/j.1749-6632.1982.tb21392.x. [DOI] [PubMed] [Google Scholar]
  12. Grotendorst G. R., Chang T., Seppä H. E., Kleinman H. K., Martin G. R. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J Cell Physiol. 1982 Nov;113(2):261–266. doi: 10.1002/jcp.1041130213. [DOI] [PubMed] [Google Scholar]
  13. Hayashi Y., Lalich J. J. Renal and pulmonary alterations induced in rats by a single injection of monocrotaline. Proc Soc Exp Biol Med. 1967 Feb;124(2):392–396. doi: 10.3181/00379727-124-31748. [DOI] [PubMed] [Google Scholar]
  14. Hilliker K. S., Bell T. G., Roth R. A. Pneumotoxicity and thrombocytopenia after single injection of monocrotaline. Am J Physiol. 1982 Apr;242(4):H573–H579. doi: 10.1152/ajpheart.1982.242.4.H573. [DOI] [PubMed] [Google Scholar]
  15. Hollinger M. A., Giri S. N., Patwell S., Zuckerman J. E., Gorin A., Parsons G. Effect of acute lung injury on angiotensin converting enzyme in serum, lung lavage, and effusate. Am Rev Respir Dis. 1980 Feb;121(2):373–376. doi: 10.1164/arrd.1980.121.2.373. [DOI] [PubMed] [Google Scholar]
  16. Hollinger M. A., Patwell S. W., Zuckerman J. E., Gorin A. B., Parsons G., Giri S. N. Effect of paraquat on serum angiotensin converting enzyme. Am Rev Respir Dis. 1980 May;121(5):795–798. doi: 10.1164/arrd.1980.121.5.795. [DOI] [PubMed] [Google Scholar]
  17. Huxtable R., Ciaramitaro D., Eisenstein D. The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium. Mol Pharmacol. 1978 Nov;14(6):1189–1203. [PubMed] [Google Scholar]
  18. Jaffe E. A. Cell biology of endothelial cells. Hum Pathol. 1987 Mar;18(3):234–239. doi: 10.1016/s0046-8177(87)80005-9. [DOI] [PubMed] [Google Scholar]
  19. Jederlinic P., Hill N. S., Ou L. C., Fanburg B. L. Lung angiotensin converting enzyme activity in rats with differing susceptibilities to chronic hypoxia. Thorax. 1988 Sep;43(9):703–707. doi: 10.1136/thx.43.9.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kay J. M., Keane P. M., Suyama K. L., Gauthier D. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension. Thorax. 1982 Feb;37(2):88–96. doi: 10.1136/thx.37.2.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Keane P. M., Kay J. M. Lung angiotensin converting enzyme activity in monocrotaline pulmonary hypertension. Thorax. 1984 Feb;39(2):159–160. doi: 10.1136/thx.39.2.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Keane P. M., Kay J. M., Suyama K. L., Gauthier D., Andrew K. Lung angiotensin converting enzyme activity in rats with pulmonary hypertension. Thorax. 1982 Mar;37(3):198–204. doi: 10.1136/thx.37.3.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lafranconi W. M., Huxtable R. J. Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline. Thorax. 1983 Apr;38(4):307–309. doi: 10.1136/thx.38.4.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mattocks A. R. Toxicity of pyrrolizidine alkaloids. Nature. 1968 Feb 24;217(5130):723–728. doi: 10.1038/217723a0. [DOI] [PubMed] [Google Scholar]
  25. Mattocks A. R., White I. N. The conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat-liver microsomes in vitro. Chem Biol Interact. 1971 Oct;3(5):383–396. doi: 10.1016/0009-2797(71)90018-4. [DOI] [PubMed] [Google Scholar]
  26. Meyrick B., Reid L. Development of pulmonary arterial changes in rats fed Crotalaria spectabilis. Am J Pathol. 1979 Jan;94(1):37–50. [PMC free article] [PubMed] [Google Scholar]
  27. Molteni A., Ward W. F., Ts'ao C. H., Port C. D., Solliday N. H. Monocrotaline-induced pulmonary endothelial dysfunction in rats. Proc Soc Exp Biol Med. 1984 May;176(1):88–94. doi: 10.3181/00379727-176-41847. [DOI] [PubMed] [Google Scholar]
  28. Molteni A., Ward W. F., Ts'ao C. H., Solliday N. H., Dunne M. Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine. Proc Soc Exp Biol Med. 1985 Oct;180(1):112–120. doi: 10.3181/00379727-180-42151. [DOI] [PubMed] [Google Scholar]
  29. Oparil S., Narkates A. J., Jackson R. M., Ann H. S. Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats. J Appl Physiol (1985) 1988 Jul;65(1):218–227. doi: 10.1152/jappl.1988.65.1.218. [DOI] [PubMed] [Google Scholar]
  30. Peckham J. C., Sangster L. T., Jones O. H., Jr Crotalaria spectabilis poisoning in swine. J Am Vet Med Assoc. 1974 Oct 1;165(7):633–638. [PubMed] [Google Scholar]
  31. Powell J. S., Müller R. K., Rouge M., Kuhn H., Hefti F., Baumgartner H. R. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol. 1990;16 (Suppl 4):S42–S49. doi: 10.1097/00005344-199016004-00010. [DOI] [PubMed] [Google Scholar]
  32. Reindel J. F., Ganey P. E., Wagner J. G., Slocombe R. F., Roth R. A. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. Toxicol Appl Pharmacol. 1990 Nov;106(2):179–200. doi: 10.1016/0041-008x(90)90239-q. [DOI] [PubMed] [Google Scholar]
  33. Reindel J. F., Hoorn C. M., Wagner J. G., Roth R. A. Comparison of response of bovine and porcine pulmonary arterial endothelial cells to monocrotaline pyrrole. Am J Physiol. 1991 Dec;261(6 Pt 1):L406–L414. doi: 10.1152/ajplung.1991.261.6.L406. [DOI] [PubMed] [Google Scholar]
  34. Reindel J. F., Roth R. A. The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells. Am J Pathol. 1991 Mar;138(3):707–719. [PMC free article] [PubMed] [Google Scholar]
  35. Ryan J. W. Angiotensin-converting enzyme, dipeptidyl carboxypeptidase I, and its inhibitors. Methods Enzymol. 1988;163:194–210. doi: 10.1016/0076-6879(88)63020-5. [DOI] [PubMed] [Google Scholar]
  36. SCHOENTAL R., HEAD M. A. Pathological changes in rats as a result of treatment with monocrotaline. Br J Cancer. 1955 Mar;9(1):229–237. doi: 10.1038/bjc.1955.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schweigerer L., Neufeld G., Friedman J., Abraham J. A., Fiddes J. C., Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature. 1987 Jan 15;325(6101):257–259. doi: 10.1038/325257a0. [DOI] [PubMed] [Google Scholar]
  38. Shale D. J., Wiseman M. S., Cookson W. O. Effect of monocrotaline ingestion on the distribution of protein and angiotensin converting enzyme activity in the rat lung. Thorax. 1986 Dec;41(12):914–918. doi: 10.1136/thx.41.12.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sugita T., Hyers T. M., Dauber I. M., Wagner W. W., McMurtry I. F., Reeves J. T. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J Appl Physiol Respir Environ Exerc Physiol. 1983 Feb;54(2):371–374. doi: 10.1152/jappl.1983.54.2.371. [DOI] [PubMed] [Google Scholar]
  40. Valdivia E., Lalich J. J., Hayashi Y., Sonnad J. Alterations in pulmonary alveoli after a single injection of monocrotaline. Arch Pathol. 1967 Jul;84(1):64–76. [PubMed] [Google Scholar]
  41. Yang H. Y., Erdös E. G., Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta. 1970 Aug 21;214(2):374–376. doi: 10.1016/0005-2795(70)90017-6. [DOI] [PubMed] [Google Scholar]
  42. Zakheim R. M., Mattioli L., Molteni A., Mullis K. B., Bartley J. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. Lab Invest. 1975 Jul;33(1):57–61. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES